Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva
Quick facts
Marketed products
- Piperacillin-tazobactam combination product · Infectious Disease
Piperacillin-tazobactam is a beta-lactam antibiotic combined with a beta-lactamase inhibitor that kills bacteria by inhibiting cell wall synthesis while protecting the antibiotic from enzymatic degradation.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva portfolio CI brief
- Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva pipeline updates RSS
Frequently asked questions about Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva
What are Gruppo Italiano per la Valutazione degli Interventi in Terapia Intensiva's marketed drugs?
Top marketed products include Piperacillin-tazobactam combination product.
Related
- Piperacillin-tazobactam combination product · Infectious Disease
- Sector hub: All tracked pharma companies